ЛИТЕРАТУРА
1. Mendis S., Davis S., Norrving B. The World Health Organization Global Status Report on Noncommunicable Diseases 2014 // Stroke. 2015. Vol. 46. P. 121-123.
2. Дедов И.И., Шестакова М.В., Галстян Г.Р. Распространенность сахарного диабета 2 типа у взрослого населения России (исследование NATION) // Сахарный диабет. 2016. Т.19, № 2. C. 104-112.
3. Дедов И.И., Шестакова М.В. Сахарный диабет. Диагностика. Лечение. Профилактика. М. : МИА, 2011.
4. Балаболкин М.И. Патогенез и механизмы развития ангиопатий при сахарном диабете // Кардиология. 2000. № 10. С. 74-87.
5. Le Devehat C., Vimeux M., Khodabandehlou T. Blood rheology in patients with diabetes mellitus // Clin. Hemorheol. Microcirc. 2004. Vol. 30. P. 297.
6. Муравьев А.В., Тихомиров И.А., Михайлов П.В., Муравьева А.А. Гемореология и микроциркуляция: уч. пособие. Ярославль, 2010.
7. Skovborg F., Nielsen A.V., Schlichtkrull J., Ditzel J. Blood-viscosity in diabetic patients // Lancet. 1966. Vol. 1, N 7429. P. 129-131.
8. Киричук В.Ф., Киричук В.Ф., Болотова Н.В., Николаева Н.В. Изменения микроциркуляторного гемостаза и реологии при сахарном диабете // Тромбоз, гемостаз и реология. 2004. № 4. С. 12-19.
9. Cho Y.I., Mooney M.P., Cho D.J. Hemorheological disorders in diabetes mellitus // J. Diabetes Sci. Technol. 2006. Vol. 2, N 6. P. 24-28.
10. Loyola-Leyva A., Loyola-Rodriguez J.P., Atzori M., Gonzalez F.J. Morphological changes in erythrocytes of people with type 2 diabetes mellitus evaluated with atomic force microscopy: a brief review. // Micron. 2018. Vol. 105. P. 11-17.
11. Barnes A.J., Locke P., Dormandy T.L., Dormandy J.A. Blood viscosity and metabolic control in diabetes mellitus // Clin. Sci. Mol. Med. 1977. Vol. 52. P. 24-25.
12. Ozmen B., Boyvada S. The relationship between self-monitoring of blood glucose control and glycosylated haemoglobin in patients with type 2 diabetes with and without diabetic retinopathy // J. Diabetes Complications. 2003. Vol. 17, N 3. P. 128-134.
13. GrigoLeit H.G., Lehrach F., MuLLer R. Diabetic angiopathy and bLood viscosity // Acta Diabet. Lat. 1973. VoL. 10. P. 1311-1324.
14. HiLz M.J., MarthoL H., Neundorfer B. Diabetic somatic poLyneuropathy. Pathogenesis, cLinicaL manifestations and therapeutic concepts // Fortschr. NeuroL. Psychiatr. 2000. VoL. 68, N 6. P. 278-288.
15. Peduzzi M., MeLLi M., Fonda S., CodeLuppi L. et aL. Comparative evaLuation of bLood viscosity in diabetic retinopathy // Int. OphthaLmoL. 1984. VoL. 7, N 1. P. 15-19.
16. Lee S., Lee M.Y., Nam J.S. et aL. HemorheoLogicaL approach for earLy detection of chronic kidney disease and diabetic nephropathy in type 2 diabetes // Diabetes TechnoL. Ther. 2015. VoL. 17, N 11. P. 808-815.
17. Mantskava M., MomtseLidze N., PargaLava N., MchedLishviLi G. HemorheoLogicaL disorders in patients with type 1 or 2 diabetes meLLitus and foot gangrene // CLin. HemorheoL. Microcirc. 2006. VoL. 35. P. 307-310.
18. Шилов А.М., Мельник М.В. Артериальная гипертония и реологические свойства крови. М. : БАРС, 2005.
19. Фирсов Н.Н., Джанашия П.Х. Введение в экспериментальную и клиническую реологию. М. : Изд-во РГМУ, 2008.
20. Korotaeva T.V., Firsov N.N., BjeLLe A., VishLova M.A. Erythrocytes aggregation in heaLthy donors at native and standard hematocrit: the infLuence of sex, age, immunogLobuLins and fibrinogen concentrations. Standardization of parameters // CLin. HemorheoL. Microcirc. 2007. VoL. 36. P. 335-343.
21. Bronkhorst P.J., Grimbergen J., Brakenhoff G.J., Heethaar R.M. et aL. The mechanism of red ceLL (dis)aggregation investigated by means of direct ceLL manipuLation using muLtipLe opticaL trapping // Br. J. HaematoL. 1997. VoL. 96. P. 256-258.
22. Priezzhev A.V., Lee K., Wagner C. Assessment of the "cross-bridge"-induced interaction of red bLood ceLLs by opticaL trapping combined with microfLuidics // J. Biomed. Opt. 2017. VoL. 22, N 9. ArticLe ID 091516.
23. Chien S., Sung L.A. PhysiochemicaL basis and cLinicaL impLications of red ceLL aggregation // CLin. HemorheoL. Microcirc. 1987. VoL. 7. P. 71-91.
24. Schmid-Schdnbein H., VoLger E. Red-ceLL aggregation and red-ceLL deformabiLity in diabetes // Diabetes. 1996. VoL. 25, N 2. P. 897-902.
25. Budak Y., Demirci H., Akdogan M., Yavuz D. Erythrocyte membrane anionic charge in type 2 diabetic patients with retinopathy // BMC OphthaLmoL. 2004. VoL. 4. P. 14.
26. Wautier J.-L. BLood ceLLs and vascuLar ceLL interaction and in diabetes // CLin. HemorheoL. Microcirc. 2001. VoL. 25. P. 49-53.
27. Torregiani F., Umansky-Zeverin M., RiqueLine B., Rasia R. HemorheoLogicaL aLterations in diabetic patients // CLin. HemorheoL. 1995. VoL. 15. P. 687.
28. Singh M., Shin S. Changes in erythrocyte aggregation and deformabiLity in diabetes meLLitus: a brief review // Indian J. Exp. BioL. 2009. VoL. 47. P. 7-15.
29. Babu N., Singh M. Influence of hypergLycemia on aggregation, deformabiLity and shape parameters of erythrocytes // CLin. HemorheoL. Microcirc. 2004. VoL. 31, N 4. P. 273-280.
30. ELishkevitz K., Fusman R., KoffLer M., Shapira I. et aL. RheoLogicaL determinants of red bLood ceLL aggregation in diabetic patients in reLation to their metaboLic controL // Diabet. Med. 2002. VoL. 19, N 2. P. 152-156.
31. ZiegLer O., Guerci B., MuLLer S., CandiLoros H. et aL. Increased erythrocyte aggregation in insuLin-dependent diabetes meLLitus and its reLationship to pLasma factors: a muLtivariate anaLysis // MetaboLism. 1994. VoL. 43, N 9. P. 1182-1186.
32. SokoLova I.A., KachaLova A.V., Fabrichnova A.A., KovaLeva Yu.A. et aL. HemorheoLogicaL properties in patients with type-1 and type-2 diabetes meLLitus // J. Biomed. Photonics Eng. 2016. VoL. 3, N 3. P. 21-26.
33. Федюшина О.Г. Особенности гемостаза и реологии крови человека при сахарном диабете в сочетании с артериальной гипертензией : дис. ... канд. биол. наук. Н. Новгород, 2005.
34. AttaLi J.R., VaLensi P. Diabetes and hemorheoLogy // Diabetes Metab. 1990. VoL. 16, N 1. P. 1-6.
35. Семенов А.Н., Луговцов А.Е., Ли К., Фабричнова А.А. и др. Использование методов диффузного рассеяния света и оптического захвата для исследования реологических свойств крови: агрегация эритроцитов при сахарном диабете // Изв. Сарат. ун-та. Нов. сер. Сер. Физика. 2017. Т. 17, № 2. С. 85-97.
36. Le Devehat C., KhodabandehLou T., Vimeux M. Impaired hemorheoLogicaL properties in diabetic patients with Lower Limb arteriaL ischaemia // CLin. HemorheoL. 2001. VoL. 25. P. 43.
37. Cinara L., BoLLini A., GayoL M. deL C., Hernandez G.N. In vitro effect of insuLin on rats erythrocytes rheoLogicaL behavior // CLin. HemorheoL. Microcirc. 2006. VoL. 35, N 3. P. 367-373.
38. CoppoLa L., Verrazzo G., La Marca C., Ziccardi P. et aL. Effect of insuLin on bLood rheoLogy in non-diabetic subjects and in patients with type 2 diabetes meLLitus // Diabet. Med. 1997. VoL. 14, N 11. P. 959-963.
39. Cho M., Shin S., Kwon H.M., Chung H. et aL. Effect of cLinicaL and RBC hemorheoLogicaL parameters on myocardiaL perfusion in patients with type 2 diabetes meLLitus // BiorheoLogy. 2014. VoL. 51, N 2-3. P. 215-226.
40. Wautier J.L. BLood ceLL-vesseL waLL interactions // CLin. HemorheoL. Microcirc. 1992. VoL. 12. P. 55-58.
41. Кузник Б.И., Витковский Ю.А., Захарова М.Ю., Ключерева Н.Н. и др. Агрегационная активность форменных элементов крови у больных сахарным диабетом 1 и 2 типа // Сахарный диабет. 2012. № 2. С. 49-53.
42. Кузник Б.И. Клеточные и молекулярные механизмы регуляции системы гемостаза в норме и патологии. Чита : Экспресс-издательство, 2010. C. 828.
43. Зубаиров Д.М, Зубаирова Л.М. Эндотелиальные микровезикулы - посредники межклеточных взаимодействий в сосудистом секторе // Тромбоз, гемостаз и реология. 2011. № 2. С. 5-13.
44. Firsov N.N., Priezzhev A.V., KLimova N.V., Tyrina A.Yu. FundamentaL Laws of the deformationaL behavior of erythrocytes in shear flow // J. Eng. Phys. Thermophys. 2006. VoL. 79, N 1. P. 118-124.
45. Кравец Е.Б., Яковлева Н.М., Рязанцева Н.В. Особенности микрореологических свойств эритроцитов при сосудистых осложнениях сахарного диабета 1 типа // Сахарный диабет. 2005. № 1. C. 14-17.
46. Symeonidis A., Athanassiou G., Psiroyannis A., KyriazopouLou V. et aL. Impairment of erythrocyte viscoeLasticity is correLated with LeveLs of gLycosyLated hemogLobin in diabetic patients // CLin. Lab. HaematoL. 2001. VoL. 23. P. 103.
47. WataLa C., Zawodniak M., Bryszewska M., Nowak S. Nonenzymatic protein gLycosyLation. Lowered erythrocyte membrane fLuidity in juveniLe diabetes // Ann. CLin. Res. 1985. VoL. 17, N 6. P. 327-330.
48. Babu N., Singh M. InfLuence of hypergLycemia on aggregation, deformabiLity and shape parameters of erythrocytes // CLin. HemorheoL. Microcir. 2004. VoL. 31. P. 273.
49. Schwartz R.S., Madsen J.W., Rybicki A.C., NageL R.L. Oxidation of spectrin and deformabiLity defects in diabetic erythrocytes // Diabetes. 1991. VoL. 40. P. 701.
50. Tsukada K., Sekizuka E., Oshio C., Minamitani H. Direct measurement of erythrocyte deformabiLity in diabetes meLLitus with a transparent micro-channeL capiLLary modeL and high-speed video camera system // Microvasc. Res. 2001. VoL. 61. P. 231.
51. Le Devehat C., KhodabandehLou T., Vimeux M. ReLationship between hemorheoLogicaL and microcircuLatory abnormaLities in diabetes meLLitus // Diabetes Metab. 1994. VoL. 20, N 4. P. 401-404.
52. Zimny S., DesseL F., Ehren M., PfohL M. et aL. EarLy detection of microcircuLatory impairment in diabetic patients with foot at risk // Diabetes Care. 2001. VoL. 24, N 10. P. 1810-1814.
53. Shin S., Ku Y.H., Suh J.S., Singh M. RheoLogicaL characteristics of erythrocytes incubated in gLucose media // CLin. HemorheoL. Microcirc. 2008. VoL. 38, N 3. P. 153-161.
54. GurfinkeL Yu.I., Suchkova O.V., Sasonko M.L., Priezzhev A.V. ImpLementation of digitaL opticaL capiLLaroscopy for quantifying and estimating the microvascuLar abnormaLities in type 2 diabetes meLLitus // Saratov FaLL Meeting 2015: Third InternationaL Symposium on Optics and Biophotonics and Seventh Finnish-Russian Photonics and Laser Symposium (PALS). Proc. SPIE BeLLingham, Washington, 2016. ArticLe ID 91703.
REFERENCES
1. Mendis S., Davis S., Norrving B. The WorLd HeaLth Organization GLobaL Status Report on NoncommunicabLe Diseases 2014. Stroke. 2015; 46: 121-3.
2. Dedov I.I., Shestakova M.V., GaLstyan G.R. The prevaLence of type 2 diabetes meLLitus in the aduLt popuLation of Russia (NATION study). Sakharniy diabet [Diabetes MeLLitus]. 2016; 19 (2): 104-12. (in Russian)
3. Dedov I.I., Shestakova M.V. Diabetes meLLitus. Diagnostics. Treatment. Prevention. Moscow: MIA, 2011. (in Russian)
4. BaLaboLkin M.I. Pathogenesis and mechanisms of angiopathy in diabetes meLLitus. KardioLogiya [CardioLogy]. 2000; (10): 74-87. (in Russian)
5. Le Devehat C., Vimeux M., KhodabandehLou T. BLood rheoLogy in patients with diabetes meLLitus. CLin HemorheoL Microcir. 2004; 30: 297.
6. Murav'ev A.V., Tikhomirov I.A., MikhayLov P.V., Muravieva A.A. HaemorheoLogy and microcircuLation: a textbook. YarosLavL', 2010. (in Russian)
7. Skovborg F., NieLsen A.V., SchLichtkruLL J., DitzeL J. BLood-viscosity in diabetic patients. Lancet. 1966; 1 (7429): 129-31.
8. Kirichuk, V.F., Kirichuk V.F., BoLotova, N.V. NikoLaeva N.V. Changes in microcircuLatory hemostasis and rheoLogy in diabetes meLLitus. Tromboz, gemostaz i reoLogiya [Thrombosis, Hemostasis and RheoLogy]. 2004; (4): 12-9. (in Russian)
9. Cho Y.I., Mooney M.P., Cho D.J. HemorheoLogicaL disorders in diabetes meLLitus. J Diabetes Sci TechnoL. 2006; 2 (6): 24-8.
10. LoyoLa-Leyva A., LoyoLa-Rodriguez J.P., Atzori M., GonzaLez F.J. MorphoLogicaL changes in erythrocytes of peopLe with type 2 diabetes meLLitus evaLuated with atomic force microscopy: a brief review. Micron. 2018; 105: 11-7.
11. Barnes A.J., Locke P., Dormandy T.L., Dormandy J.A. BLood viscosity and metaboLic controL in diabetes meLLitus. CLin Sci MoL Med. 1977; 52: 24-5.
12. Ozmen B., Boyvada S. The reLationship between seLf-monitoring of bLood gLucose controL and gLycosyLated haemogLobin in patients with type 2 diabetes with and without diabetic retinopathy. J Diabetes CompLications. 2003; 17 (3): 128-34.
13. GrigoLeit H.G., Lehrach F., MuLLer R. Diabetic angiopathy and bLood viscosity. Acta Diabet Lat. 1973; 10: 1311-24.
14. HiLz M.J., MarthoL H., Neundorfer B. Diabetic somatic poLyneuropathy. Pathogenesis, cLinicaL manifestations and therapeutic concepts. Fortschr NeuroL Psychiatr. 2000; 68 (6): 278-88.
15. Peduzzi M., MeLLi M., Fonda S., CodeLuppi L., et aL. Comparative evaLuation of bLood viscosity in diabetic retinopathy. Int OphthaLmoL. 1984; 7 (1): 15-9.
16. Lee S., Lee M.Y., Nam J.S., et aL. HemorheoLogicaL approach for earLy detection of chronic kidney disease and diabetic nephropathy in type 2 diabetes. Diabetes TechnoL Ther. 2015; 17 (11): 808-15.
17. Mantskava M., MomtseLidze N., PargaLava N., MchedLishviLi G. HemorheoLogicaL disorders in patients with type 1 or 2 diabetes meLLitus and foot gangrene. CLin HemorheoL Microcirc. 2006; 35: 307-10.
18. ShiLov A.M., MeLnik M.V. ArteriaL hypertension and rheoLogicaL properties of bLood. Moscow: BARS, 2005. (in Russian)
19. Firsov N.N., Dzhanashiya P.Kh. Introduction to experimentaL and cLinicaL rheoLogy. Moscow : IzdateL'stvo RGMU, 2008. (in Russian)
20. Korotaeva T.V., Firsov N.N., BjeLLe A., VishLova M.A. Erythrocytes aggregation in heaLthy donors at native and standard hematocrit: the influence of sex, age, immunogLobuLins and fibrinogen concentrations. Standardization of parameters. CLin HemorheoL Microcirc. 2007; 36: 335-43.
21. Bronkhorst P.J., Grimbergen J., Brakenhoff G.J., Heethaar R.M., et aL. The mechanism of red ceLL (dis)aggregation investigated by means of direct ceLL manipuLation using muLtipLe opticaL trapping. Br J HaematoL. 1997; 96: 256-8.
22. Priezzhev A.V., Lee K., Wagner C. Assessment of the "cross-bridge"-induced interaction of red bLood ceLLs by opticaL trapping combined with microfLuidics. J Biomed Opt. 2017; 22 (9): 091516.
23. Chien S., Sung L.A. PhysiochemicaL basis and cLinicaL impLications of red ceLL aggregation. CLin HemorheoL Microcirc. 1987; 7: 71-91.
24. Schmid-Schonbein H., VoLger E. Red-ceLL aggregation and red-ceLL deformabiLity in diabetes. Diabetes. 1996; 25 (2): 897-902.
25. Budak Y., Demirci H., Akdogan M., Yavuz D. Erythrocyte membrane anionic charge in type 2 diabetic patients with retinopathy. BMC OphthaLmoL. 2004; 4: 14.
26. Wautier J.-L. BLood ceLLs and vascuLar ceLL interaction and in diabetes. CLin HemorheoL Microcirc. 2001; 25: 49-53.
27. Torregiani F., Umansky-Zeverin M., RiqueLine B., Rasia R. HemorheoLogicaL aLterations in diabetic patients. CLin HemorheoL. 1995; 15: 687.
28. Singh M., Shin S. Changes in erythrocyte aggregation and deformabiLity in diabetes meLLitus: a brief review. Indian J Exp BioL. 2009; 47: 7-15.
29. Babu N., Singh M. Influence of hypergLycemia on aggregation, deformabiLity and shape parameters of erythrocytes. CLin HemorheoL Microcirc. 2004; 31 (4): 273-80.
30. ELishkevitz K., Fusman R., KoffLer M., Shapira I., et aL. RheoLogicaL determinants of red bLood ceLL aggregation in diabetic patients in reLation to their metaboLic controL. Diabet Med. 2002; 19 (2): 152-6.
31. ZiegLer O., Guerci B., MuLLer S., CandiLoros H., et aL. Increased erythrocyte aggregation in insuLin-dependent diabetes meLLitus and its reLationship to pLasma factors: a muLtivariate anaLysis. MetaboLism. 1994; 43 (9): 1182-6.
32. SokoLova I.A., KachaLova A.V., Fabrichnova A.A., KovaLeva Yu.A., et aL. HemorheoLogicaL properties in patients with type-1 and type-2 diabetes meLLitus. J Biomed Photonics Eng. 2016; 3 (3): 21-6.
33. Fedyushina O.G. Features of hemostasis and rheoLogy of human bLood in diabetes meLLitus in combination with arteriaL hypertension: Autoabstract of Diss. Nizhniy Novgorod. 2005. (in Russian)
34. AttaLi J.R., VaLensi P. Diabetes and hemorheoLogy. Diabetes Metab. 1990; 16 (1): 1-6.
35. Semenov A.N., Lugovtsov A.E., Li K., Fabrichnova A.A., et aL. AppLying methods of diffuse Light scattering and opticaL trapping for assessing bLood rheoLogicaL parameters: erythrocytes aggregation in diabetes meLLitus. Izvestiya Saratovskogo university. Novaya seriya. Seriya: Fizika [Proceedings of the Saratov University. New Series. Series Physics]. 2017; 17 (2): 85-97. (in Russian)
36. Le Devehat C., KhodabandehLou T., Vimeux M. Impaired hemorheoLogicaL properties in diabetic patients with Lower Limb arteriaL ischaemia. CLin HemorheoL. 2001; 25: 43.
37. Cinara L., BoLLini A., GayoL M. deL C., Hernandez G.N. In vitro effect of insuLin on rats erythrocytes rheoLogicaL behavior. CLin HemorheoL Microcirc. 2006; 35 (3): 367-73.
38. CoppoLa L., Verrazzo G., La Marca C., Ziccardi P., et aL. Effect of insuLin on bLood rheoLogy in non-diabetic subjects and in patients with type 2 diabetes meLLitus. Diabet Med. 1997; 14 (11): 959-63.
39. Cho M., Shin S., Kwon H.M., Chung H., et aL. Effect of cLinicaL and RBC hemorheoLogicaL parameters on myocardiaL perfusion in patients with type 2 diabetes meLLitus. BiorheoLogy. 2014; 51 (2-3): 215-26.
40. Wautier J.L. BLood ceLL-vesseL waLL interactions. CLin HemorheoL Microcirc. 1992; 12: 55-8.
41. Kuznik B.I., Vitkovskiy Yu.A., Zakharova M.Yu., KLyuchereva N.N., et aL. Aggregation activity of bLood formed eLements in patients with type 1 and type 2 diabetes meLLitus. Sakharniy diabet [Diabetes MeLLitus]. 2012; (2): 49-53. (in Russian)
42. Kuznik B.I. CeLLuLar and moLecuLar mechanisms of hemostasis reguLation in norm and pathoLogy. Chita: Ekspress-izdateL'stvo, 2010: 828 p. (in Russian)
43. Zubairov D.M., Zubairova L.M. EndotheLiaL microvesicLes - mediators of interceLLuLar interactions in the vascuLar sector. Tromboz, gemostaz i reoLogiya [Thrombosis, Hemostasis and RheoLogy]. 2011; (2): 5-13. (in Russian)
44. Firsov N.N., Priezzhev A.V., KLimova N.V., Tyrina A.Yu. FundamentaL Laws of the deformationaL behavior of erythrocytes in shear fLow. J Eng Phys Thermophys. 2006; 79 (1): 118-24.
45. Kravets E.B., YakovLeva N.M., Ryazantseva N.V. Features of micror-heoLogicaL properties of erythrocytes in vascuLar compLications of type 1 diabetes meLLitus. Sakharniy diabet [Diabetes MeLLitus]. 2005; (1): 14-7. (in Russian)
46. Symeonidis A., Athanassiou G., Psiroyannis A., KyriazopouLou V., et aL. Impairment of erythrocyte viscoeLasticity is correLated with LeveLs of gLycosyLated hemogLobin in diabetic patients. CLin Lab HaematoL. 2001; 23: 103.
47. WataLa C., Zawodniak M., Bryszewska M., Nowak S. Nonenzymatic protein gLycosyLation. Lowered erythrocyte membrane fLuidity in juveniLe diabetes. Ann CLin Res. 1985; 17 (6): 327-30.
48. Babu N., Singh M. Influence of hypergLycemia on aggregation, deformabiLity and shape parameters of erythrocytes. CLin HemorheoL Microcir. 2004; 31: 273.
49. Schwartz R.S., Madsen J.W., Rybicki A.C., NageL R.L. Oxidation of spectrin and deformabiLity defects in diabetic erythrocytes. Diabetes. 1991; 40: 701.
50. Tsukada K., Sekizuka E., Oshio C., Minamitani H. Direct measurement of erythrocyte deformabiLity in diabetes meLLitus with a transparent micro-channeL capiLLary modeL and high-speed video camera system. Microvasc Res. 2001; 61: 231.
51. Le Devehat C., KhodabandehLou T., Vimeux M. ReLationship between hemorheoLogicaL and microcircuLatory abnormaLities in diabetes meLLitus. Diabetes Metab. 1994; 20 (4): 401-4.
52. Zimny S., DesseL F., Ehren M., PfohL M., et aL. EarLy detection of microcircuLatory impairment in diabetic patients with foot at risk. Diabetes Care. 2001; 24 (10): 1810-4.
53. Shin S., Ku Y.H., Suh J.S., Singh M. RheoLogicaL characteristics of erythrocytes incubated in gLucose media. CLin HemorheoL Microcirc. 2008; 38 (3): 153-61.
54. GurfinkeL Yu.I., Suchkova O.V., Sasonko M.L., Priezzhev A.V. ImpLementation of digitaL opticaL capiLLaroscopy for quantifying and estimating the microvascuLar abnormaLities in type 2 diabetes meLLitus. In: Saratov FaLL Meeting 2015: Third InternationaL Symposium on Optics and Biophotonics and Seventh Finnish-Russian Photonics and Laser Symposium (PALS). Proc. SPIE BeLLingham, Washington, 2016: 991703.